Editas Medicine, Inc. Common Stock EDIT
$2.70
-0.74%
at last close
Financials (TTM)
- Revenue
- $47.01 million
- Net Income
- $-73,949,000
- Net Margin
- -157.32%
- Return on Equity
- -70.24%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 3.94
- Price / Sales
- 8.82
Over the trailing twelve months, Editas Medicine, Inc. Common Stock generated revenue of $47.01 million and net income of $-73,949,000, a net margin of -157.32%.
At the last closing price of $2.70, EDIT trades at 8.82 times sales, with a market capitalization of $414.67 million.
Key Stats
- Last Close
- $2.70
- Market Cap
- $414.67 million
- 52-Week Range
- $1.66 – $4.54
- Average Volume
- 2.98 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.